Brief: Revvity To Acquire Human Cell Design To Advance Human-Relevant Cell Models For Metabolic Disease Drug Discovery
09/09/2026 11:23
BRIEF-Revvity To Acquire Human Cell Design To Advance Human-Relevant Cell Models For Metabolic Disease Drug Discovery Sept 9 (Reuters) - Revvity, Inc. RVTY.N:
REVVITY TO ACQUIRE HUMAN CELL DESIGN TO ADVANCE HUMAN-RELEVANT CELL MODELS FOR METABOLIC DISEASE DRUG DISCOVERY
REVVITY, INC.: ADDITIONAL TERMS OF TRANSACTION WERE NOT DISCLOSED
REVVITY, - ACQUISITION ADDS HCD'S HUMAN PANCREATIC BETA CELL MODELS TO REVVITY PORTFOLIO
Source text: ID:nBw5FWdDna
Further company coverage: RVTY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revvity
See all newsBrief: Revvity Launches Signals Labgistics Solution To Connect And Orchestrate Scientific Workflows
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT